Trxade Group (MEDS)
NASDAQ:MEDS
Holding MEDS?
Track your performance easily

Trxade Group (MEDS) Stock Price & Analysis

150 Followers

MEDS Stock Chart & Stats


Financials

Annual

Ownership Overview

41.94%1.37%1.44%55.25%
41.94% Insiders
1.44% Other Institutional Investors
55.25% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

MEDS FAQ

What was Trxade Group’s price range in the past 12 months?
Trxade Group lowest stock price was $3.69 and its highest was $44.56 in the past 12 months.
    What is Trxade Group’s market cap?
    Currently, no data Available
    When is Trxade Group’s upcoming earnings report date?
    Trxade Group’s upcoming earnings report date is Jul 22, 2024 which is 60 days ago.
      How were Trxade Group’s earnings last quarter?
      Currently, no data Available
      Is Trxade Group overvalued?
      According to Wall Street analysts Trxade Group’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Trxade Group pay dividends?
        Trxade Group pays a Notavailable dividend of $1.5 which represents an annual dividend yield of N/A. See more information on Trxade Group dividends here
          What is Trxade Group’s EPS estimate?
          Trxade Group’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Trxade Group have?
          Trxade Group has 1,750,042 shares outstanding.
            What happened to Trxade Group’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Trxade Group?
            Currently, no hedge funds are holding shares in MEDS
            ---

            Trxade Group Stock Smart Score

            Company Description

            Trxade Group

            Trxade Group, Inc. provides an on-line platform for pharmaceutical purchasers. It owns and operates a business-to-business web-based marketplace focuses on the United States pharmaceutical industry. It operates web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services; provides state-licensed pharmacies and buying groups in the United States with pharmaceuticals approved by the United States Food and Drug Administration; and acts as technology consultant provider that supports their programming needs and provides research on pharmaceutical pricing and shortages in acute care and retail settings. The company was founded on July 15, 2005 and is headquartered in Land O' Lakes, FL.
            ---

            MEDS Earnings Call

            Q1 2023
            0:00 / 0:00
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Aclaris Therapeutics
            Avadel Pharmaceuticals
            Evolus
            Karyopharm Therapeutics
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis